Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 8Thoracic 3Head & Neck 2Breast 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 234Head and Neck Neoplasms 123Carcinoma, Non-Small-Cell Lung 78Melanoma 73Colorectal Neoplasms 43Carcinoma, Renal Cell 43Neoplasm Metastasis 35Neoplasms 33Triple Negative Breast Neoplasms 31Uterine Cervical Neoplasms 30Stomach Neoplasms 30Carcinoma, Transitional Cell 30Breast Neoplasms 30Lung Neoplasms 29Ovarian Neoplasms 28Carcinoma, Squamous Cell 24Pancreatic Neoplasms 23Carcinoma 23Esophageal Neoplasms 20Endometrial Neoplasms 19Oropharyngeal Neoplasms 18Mouth Neoplasms 18Carcinoma, Hepatocellular 18Small Cell Lung Carcinoma 17Parkinson Disease 4, Autosomal Dominant Lewy Body 16Urinary Bladder Neoplasms 13Nasopharyngeal Carcinoma 13Laryngeal Neoplasms 13Prostatic Neoplasms 12Mesothelioma 12

Interventions

pembrolizumab 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1seribantumab 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1defactinib 1dabrafenib 1copanlisib 1cemiplimab 1capivasertib 1binimetinib 1adavosertib 1X-Rays 1Trastuzumab 1Sunitinib 1Specimen Handling 1Robotic Surgical Procedures 1Radionuclide Imaging 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Neoplasms × pembrolizumab × Head & Neck × Clear all
NCT03476681 2025-04-24

Study of NEO-201 in Solid Tumors Expansion Cohorts

Precision Biologics, Inc

Phase 1/2 Recruiting
121 enrolled
GynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Uterine Neoplasms

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Kineta Inc.

Phase 1/2 Unknown
314 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡